Report #2830316

Overview

Sex

Female

Age

26 yrs

State

TX

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

A 26 years old female patient received a dose of Priorix via IM instead of SC.; dose of Priorix via IM instead of SC; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 26-year-old female patient who received MMR (Priorix) (batch number XX9N4, expiry date 01-JUN-2026) for prophylaxis. On an unknown date, the patient received Priorix (intramuscular). On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate age at vaccine administration (Verbatim: A 26 years old female patient received a dose of Priorix via IM instead of SC.) and subcutaneous injection formulation administered by other route (Verbatim: dose of Priorix via IM instead of SC). The outcome of the inappropriate age at vaccine administration and subcutaneous injection formulation administered by other route were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 28-FEB-2025 A pharmacist called to report that a 26 years old female patient received a dose of Priorix via intramuscular instead of Subcutaneous which led to Subcutaneous injection formulation administered by other route. Should the patient be revaccinated. The reporter consented to follow up.